RS20060255A - Quick test for the diagnosis of alzheimer's disease - Google Patents

Quick test for the diagnosis of alzheimer's disease

Info

Publication number
RS20060255A
RS20060255A YUP-2006/0255A YUP20060255A RS20060255A RS 20060255 A RS20060255 A RS 20060255A YU P20060255 A YUP20060255 A YU P20060255A RS 20060255 A RS20060255 A RS 20060255A
Authority
RS
Serbia
Prior art keywords
disease
alzheimer
diagnosis
quick test
predisposition
Prior art date
Application number
YUP-2006/0255A
Other languages
English (en)
Inventor
Thomas Arendt
Jens Stieler
Original Assignee
Universitat Leipzig,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitat Leipzig, filed Critical Universitat Leipzig,
Publication of RS20060255A publication Critical patent/RS20060255A/sr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70514—CD4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G01N2333/70517—CD8
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/7056—Selectin superfamily, e.g. LAM-1, GlyCAM, ELAM-1, PADGEM
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)

Abstract

Dati pronalazak odnosi se na postupak za postavljanje dijagnoze za Alchajmerovu bolest ili početnu fazu bolesti ili predispozicije za ovo oboljenje, gde se postupak zasniva na kvantifikaciji mitogenski izraženih površinskih markera, po mogućstvu CD69, i periferno pristupačnih ćelija, kao što su na primer, ćelije kože ili limfocita, (a) pre i (b) nakon mitogene stimulacije, gde specifični indeks stimulacije a: b predstavlja znak prisustva Alchajmerove bolesti ili rane faze iste ili predispozicije za ovo oboljenje. Dati pronalazak se takodje odnosi na kitove pogodne za izvodjenje dijagnostičkih postupaka prema pronalasku
YUP-2006/0255A 2003-10-22 2004-09-29 Quick test for the diagnosis of alzheimer's disease RS20060255A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10349162A DE10349162A1 (de) 2003-10-22 2003-10-22 Schnelltest zur Diagnose der Alzheimerschen Erkrankung
PCT/EP2004/010889 WO2005050219A1 (de) 2003-10-22 2004-09-29 Schnelltest zur diagnose der alzheimerschen erkrankung

Publications (1)

Publication Number Publication Date
RS20060255A true RS20060255A (en) 2008-09-29

Family

ID=34529710

Family Applications (2)

Application Number Title Priority Date Filing Date
YUP-2006/0255A RS20060255A (en) 2003-10-22 2004-09-29 Quick test for the diagnosis of alzheimer's disease
RS20060255A RS52875B (sr) 2003-10-22 2004-09-29 Test za brzo dijagnostikovanje alchajmerove bolesti

Family Applications After (1)

Application Number Title Priority Date Filing Date
RS20060255A RS52875B (sr) 2003-10-22 2004-09-29 Test za brzo dijagnostikovanje alchajmerove bolesti

Country Status (15)

Country Link
US (2) US20070218497A1 (sr)
EP (1) EP1685408A1 (sr)
JP (1) JP2007509331A (sr)
KR (1) KR101138343B1 (sr)
CN (1) CN1871519A (sr)
AU (1) AU2004290789B2 (sr)
BR (1) BRPI0415212A (sr)
CA (1) CA2540841A1 (sr)
DE (1) DE10349162A1 (sr)
IL (1) IL175004A0 (sr)
NO (1) NO335704B1 (sr)
RS (2) RS20060255A (sr)
RU (1) RU2426130C2 (sr)
WO (1) WO2005050219A1 (sr)
ZA (1) ZA200603178B (sr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1876449A1 (en) * 2006-07-07 2008-01-09 Universität Leipzig Cell cycle-based blood test to diagnose Alzheimer's disease
CA2749886C (en) * 2009-01-20 2018-12-04 Cambridge Enterprise Limited Methods for predicting autoimmune disease risk
GB201212084D0 (en) * 2012-07-06 2012-08-22 Randox Lab Ltd Tropomyosin isoforms related to alzheimers disease and mild cognitive impairment
EP3011336A4 (en) * 2013-06-20 2017-01-04 Amarantus Bioscience Holdings Inc. Methods, systems, and composition related to neural disorders
CN106885909B (zh) * 2017-01-19 2018-11-20 上海市东方医院 一种用于早期诊断阿尔茨海默病的试剂盒
EP3593136A1 (en) * 2017-03-06 2020-01-15 Talaris Therapeutics, Inc. Methods and compositions for determining the potency of a therapeutic cellular composition
MX2022000444A (es) * 2019-07-10 2022-02-10 Todos Medical Ltd Un biomarcador para la enfermedad de alzheimer utilizando muestras de sangre de sujetos con diagnostico clinico de la enfermedad de alzheimer.
CN117210549A (zh) * 2023-08-29 2023-12-12 河络新图生物科技(上海)有限公司 检测人atp5d、cd69和cxcr4基因的物质及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19936035C2 (de) * 1999-07-30 2002-11-21 Univ Leipzig Lymphozytenproliferationstestkit
US20020081635A1 (en) * 2000-05-11 2002-06-27 Thomas Terry E. Novel antibody compositions for preparing enriched T cell preparations

Also Published As

Publication number Publication date
NO20061758L (no) 2006-07-06
DE10349162A1 (de) 2005-06-02
CN1871519A (zh) 2006-11-29
AU2004290789A1 (en) 2005-06-02
EP1685408A1 (de) 2006-08-02
US20070218497A1 (en) 2007-09-20
AU2004290789B2 (en) 2010-01-21
ZA200603178B (en) 2007-07-25
CA2540841A1 (en) 2005-06-02
NO335704B1 (no) 2015-01-26
RS52875B (sr) 2013-12-31
RU2426130C2 (ru) 2011-08-10
US20150079609A1 (en) 2015-03-19
RU2006112203A (ru) 2007-11-27
IL175004A0 (en) 2006-08-20
BRPI0415212A (pt) 2006-12-05
KR101138343B1 (ko) 2012-04-26
WO2005050219A1 (de) 2005-06-02
JP2007509331A (ja) 2007-04-12
KR20060100423A (ko) 2006-09-20

Similar Documents

Publication Publication Date Title
ATE230487T1 (de) Verfahren zur frühen diagnose von carcinomen
WO2003062401A3 (en) Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
WO2003077836A3 (en) Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
HK1057217A1 (en) Method of diagnosing alzheimer' s disease on the basis of a gene transcript pattern
UA86582C2 (ru) Способ лечения хореи гентингтона ейкозапентеновой кислотой
EP1480251A3 (en) System of analyzing complex mixtures of biological and other fluids to identify biological state information
WO2006029347A3 (en) Integrin cd18 is a novel stromal stem cell marker and functions to promote osteogenesis
DE59912716D1 (de) Verfahren zur bestimmung der immunabwehraktivität des blutes sowie testkit hierfür
WO2004055196A3 (en) Method for identifying risk of breast cancer and treatments thereof
RS20060255A (en) Quick test for the diagnosis of alzheimer's disease
AU2003259222A1 (en) Method of diagnosing alzheimer's disease
WO2005121366A8 (ja) 遺伝子マーカー及びその利用
BR9906926A (pt) Composições e métodos para tratamento de células tendo dna de minuto duplo
WO2004044164A3 (en) Method for identifying risk of melanoma and treatments thereof
WO2000070340A3 (en) Materials and methods relating to disease diagnosis
WO2005027710A3 (en) Methods for identifying subjects at risk of melanoma and treatments thereof
DE50303798D1 (de) Vorrichtung, um in einem Zielgebiet eines menschlichen oder tierischen Körpers einen künstlichen isolierten Kreislauf zu etablieren
BR0111975A (pt) Fator, composição, veìculo, ligando, kits de diagnósticos, processos para detectar uma prpsc em uma amostra, e para remover prpsc de material biológico, método para diagnosticar encefalopatias espongiformes humanas transmissìveis e encefalopatias de prìons de animais, e, uso de um fator
WO2005049791A3 (en) Identification of reagents for the diagnosis and study of francisella
WO2003104812A3 (en) DIAGNOSIS ASSAY FOR ALZHEIMER'S DISEASE BASED ON THE DETERMINATION OF THE HA DOLLAR G (B) 42 RATE: HA DOLLAR G (B) 40
WO2006069592A3 (en) Method for diagnosing an/or predicting preeclampsia and/or related disorders
DE69912453D1 (de) Verfahren und materialien zur diagnose instabiler angina
WO2005045434A3 (en) Method for distinguishing aml subtypes with recurring genetic aberrations
WO2002092767A3 (en) DETECTION OF GD2 SYNTHASE mRNA AND USES THEREOF
DE50211704D1 (de) Verwendung eines markierten liganden mit spezifität für das humane cd4-molekül